Executive Overview
The intersection of women’s health, longevity, and the multi-billion-dollar beauty industry is undergoing a structural transformation. For decades, the medical establishment and the commercial beauty sector have treated the female body in isolated silos—gynecology handled reproduction, dermatology managed surface-level aging, and primary care patched together the residual symptoms.
In this fragmented landscape, millions of women navigating midlife, perimenopause, and menopause have been left to navigate a labyrinth of unaddressed physical shifts. Hormonal fluctuations trigger deep, systemic changes—from sudden collagen depletion and hyperpigmentation to chronic sleep disruption, fatigue, and adult acne—yet these concerns are frequently minimized or outright dismissed by traditional healthcare providers.
Enter Midi Health. Founded in 2021, the virtual care platform has rapidly emerged as a dominant force in women’s midlife health. By bridging the gap between clinical telehealth and targeted wellness solutions, Midi is systematically rewriting the rules of longevity care.
Most recently, the company has made strategic moves into topical skin and body care, pioneering what its Chief Medical Officer, Dr. Kathleen Jordan, MD, defines as “hormone-informed skin care.” By leveraging real-world patient data gathered from tens of thousands of weekly consultations, Midi is filling a glaring market void: clinical-grade, hormone-aware formulations designed to treat the root biochemical causes of midlife skin aging.
Backed by a formidable roster of high-profile investors—including actress and activist Connie Burch, Meghan Markle, tennis legend Brandi Chastain, and heavy-hitting institutional capital like Google Ventures and Emerson Collective—Midi Health reached a milestone $1 billion valuation following a $100 million Series D funding round in February.
This deep-dive investigation explores Midi Health’s strategic evolution into topical skin care, the science behind hormone-informed wellness, and how the platform is positioning itself to capture an increasingly discerning and underserved demographic.
Detailed Chronology: From Virtual Clinic to Wellness Powerhouse
The Genesis of a Movement (2021)
When Midi Health was launched in 2021, the virtual care landscape was crowded with general-purpose telehealth platforms and direct-to-consumer digital health startups. However, specialized care for women in midlife—specifically those traversing the turbulent years of perimenopause and menopause—remained a vast, overlooked desert.
The founders recognized that millions of women between the ages of 40 and 60 were falling through the cracks of the healthcare system. Traditional medical training often allocates minimal time to menopause management, leaving physicians unequipped to treat symptoms like brain fog, metabolic shifts, severe fatigue, and vasomotor symptoms (hot flashes) comprehensively.
Midi built its foundation on a specialized, virtual-first model staffed by clinicians trained specifically in midlife endocrinology. The platform offered targeted interventions, including hormone replacement therapy (HRT), lifestyle counseling, and prescription management.
Scaling and Symbiotic Data Gathering (2022–2023)
As Midi expanded its footprint across the United States, patient volume surged. By treating tens of thousands of women every week, the company unlocked an unprecedented feedback loop. While clinicians addressed internal symptoms like sleep disturbances and weight fluctuations, a recurring pattern emerged in patient consultations: frustration with the beauty aisle.
Patients reported spending small fortunes on luxury anti-aging creams, retinols, and serums that yielded little to no results. The disconnect was biological. Standard commercial skin care products are formulated for general anti-aging or youthful skin types, completely ignoring the structural impacts of declining estrogen, progesterone, and testosterone levels.
Midi’s medical leadership realized that their patient base was not just looking for internal wellness; they were desperately seeking topical solutions that aligned with their internal hormonal reality.
The Unicorn Valuation and Strategic Expansion (2024)
The validation of Midi’s holistic model culminated in February with a massive $100 million Series D funding round, pushing the company’s valuation to the coveted $1 billion mark. Armed with fresh capital and an engaged, growing user base, Midi began rolling out its integrated product ecosystem.
Rather than functioning as a traditional telehealth provider that merely writes prescriptions for outside pharmacies, Midi began curating and expanding its own targeted skin- and body-care selections. In June, the company introduced topical copper peptides to its lineup, sitting alongside prescription and over-the-counter staples like topical estrogen, medical-grade retinoids (tretinoin), and hyperpigmentation correctors (hydroquinone).
Today, Midi Health treats approximately 25,000 women per week, evolving from a digital clinic into a comprehensive longevity and lifestyle platform.
Supporting Context & Metrics: The Anatomy of the Midlife Market
To understand Midi Health’s market penetration, one must examine the demographic and financial dynamics driving the modern longevity economy. Women in midlife—often referred to in marketing terms as Generation Jones or Gen X, alongside older Millennials—control substantial household purchasing power and are hyper-focused on healthspan, not just lifespan.
The Clinical Reality of Hormonal Decline
Skin is an active endocrine organ. It possesses abundant receptors for estrogen, which plays a direct role in maintaining skin thickness, barrier function, hydration, and collagen production. When estrogen levels plummet during perimenopause and menopause, the skin experiences dramatic structural deterioration:
- Collagen Loss: Women can lose up to 30% of their skin’s collagen in the first five years of menopause alone, leading to reduced elasticity, sagging, and fine lines.
- Barrier Dysfunction: Decreased sebum production and lipid synthesis result in chronic dryness, irritation, and “crepey” skin textures.
- Hyperpigmentation and Adult Acne: Fluctuating androgen-to-estrogen ratios frequently trigger adult hormonal breakouts alongside stubborn sun spots and melasma.
Despite these widespread physiological shifts, the beauty industry has historically relied on blanket solutions—heavier moisturizers or generic exfoliants—rather than addressing the underlying hormonal deficit.
Investment Backing and Economic Validation
Midi Health’s $1 billion valuation is not an anomaly; it is a reflection of intense institutional and cultural appetite for women’s health innovation (often termed FemTech, though founders increasingly push past the label toward core healthcare).
The company’s cap table reads like a roll call of influential cultural and technological leaders:
- Cultural Icons and Founders: Connie Burch, Brandi Chastain, Tory Burch, Amy Schumer, and Meghan Markle.
- Institutional Capital: Google Ventures and Emerson Collective.
- Tech and Corporate Heavyweights: Sheryl Sandberg (former COO of Meta) and Tekedra Mawakana (Co-CEO of Waymo).
This cross-sector backing underscores a unified thesis: women in midlife are a massive, economically powerful demographic that has been profoundly underserved by legacy systems, creating a generational business opportunity.
Official Statements & Expert Insights
In an exclusive conversation on the Glossy Beauty Podcast, Dr. Kathleen Jordan, MD, Chief Medical Officer of Midi Health, sat down with West Coast correspondent Lexy Lebsack to unpack the philosophy driving the brand’s skin- and body-care expansion.
On "Hormone-Informed Skin Care"
Dr. Jordan emphasized that the terminology surrounding skin care must evolve to reflect biological realities.
"Women in midlife go through amazing changes with their hormones, … [and] our skin care needs actually change over time with our hormone evolution," Dr. Jordan told Glossy. "I usually talk about [this care expansion] as ‘hormone informed skin care’ because that’s really what the market’s been lacking."
She detailed how Midi’s direct connection to tens of thousands of weekly patients informs their product pipeline:
"We saw patients for many years without having [skin-care] products, but what we saw was them struggling to get good products that were actually designed for them. We now see tens of thousands of women every week, and we actually hear from them. We hear their questions. We understand where they’re struggling to get products that actually are meaningful [for their skin concerns], and then in response, we can develop products that actually help them."
The Historical Precedent and Science of Topical Estrogen
Addressing the regulatory and scientific history of active hormonal ingredients in cosmetics, Dr. Jordan offered a compelling look back:
"There are actually hormonal topical care solutions that have been historically used on women’s skin with great success. [テント example is] estrogen put in makeup in the 1950s because these makeup companies knew that it helped skin, right? As things became more regulated over decades, they had to take it out because they hadn’t done the studies, but it goes to show you that we have known for a long time that topical estrogen actually helps skin."
As board-certified hormone experts, Midi’s medical team approaches skin health through a functional lens. Dr. Jordan noted:
"If estrogen depletion is triggering some of this, does adding estrogen back in help it? We looked at these collective studies, and it does [help]. Topical estrogen products have been shown to increase collagen deposition on biopsy studies. It’s been shown to increase skin thickness, skin turgor and overall skin health. It’s also been shown to help with moisturizing and combating dry, crepey skin, which is what tretinoin didn’t have."
Engaging Patients on Longevity and Wellness
Beyond aesthetics, Dr. Jordan highlighted that skin and body care serve as an accessible entry point for comprehensive health engagement:
"Most of the women that come to Midi are in midlife, so they’re past fertility and birth issues and really looking to be their best self. To feel well and do well, and they’re becoming increasingly concerned with longevity. … They’re exhausted. They have trouble sleeping. Some of them, for the first time, are gaining weight. They’re seeing changes to their hair and skin. So we use that. We use these concerns to sort of engage them in their healthcare. This is a great time to look at what you’re doing for your own health, and really engage them in meaningful, evidence-based things they can do to feel well and do well."
Future Outlook: The Convergence of Telehealth and Beauty
As Midi Health looks toward the horizon, its trajectory signals a broader paradigm shift in how consumer health companies will operate in the latter half of the 2020s. The artificial boundary dividing clinical medicine from the wellness and beauty aisles is dissolving.
1. The Rise of Prescriptive and Clinical Wellness Retail
Consumers are increasingly skeptical of marketing hype, demanding evidence-based efficacy. Platforms like Midi, which possess trusted clinical credentials, are uniquely positioned to retail high-potency topical treatments (such as prescription retinoids, hydroquinone, and customized hormone-infused topicals) that traditional cosmetic brands cannot legally or safely distribute without medical oversight. This gives telehealth providers a distinct competitive moat against legacy beauty conglomerates.
2. Holistic Longevity as the New Standard of Care
The definition of healthcare is expanding from reactive disease management to proactive healthspan optimization. For women, this means managing the systemic transition of midlife not as an inevitable decline to be endured, but as a manageable, biologically understood phase of life. By tying internal interventions (like HRT and metabolic support) directly to external maintenance (skin and hair care), companies like Midi are capturing the entire consumer lifecycle.
3. Expansion of the Product Ecosystem
With recent additions like topical copper peptides and ongoing clinical formulation development, Midi’s product catalog is expected to expand aggressively. Future iterations may include specialized body care lines targeting crepey skin on the neck, chest, and arms—areas notoriously resistant to standard facial moisturizers and acutely impacted by post-menopausal dermal thinning.
Conclusion
Midi Health’s evolution from a digital midlife clinic into a billion-dollar telehealth and wellness ecosystem underscores a fundamental truth of the modern consumer economy: when you listen to underserved demographics and validate their lived experiences with rigorous science, the market rewards you. By pioneering hormone-informed skin care, Midi is not only filling a gap in the beauty aisle—it is setting a new standard for how modern medicine cares for women across a lifetime.
